CN Bio adds computational modeling capabilities to ADME services for enhanced bioavailability profiling
Ana Maria Rus
CN Bio Sep 3 2025 CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced the expansion of its Contract Research Services (CRS) with new PhysioMimix ® computational modeling tools. These capabilities have been developed to enhance Absorption, Distribution, Metabolism and Excretion (ADME) profiling, for accelerated drug discovery and development workflows. Image Credit: CN Bio This launch represents the
din zilele anterioare